Channelopathy pathogenesis in autism spectrum disorders

Frontiers in Genetics

Volumn 4, Issue NOV, 2013, Pages

  Schmunk, Galina ^a   Gargus, J Jay ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angelman syndrome; Calcium; Fragile X syndrome; MTOR; Prader Willi syndrome; Rett syndrome; Tuberous sclerosis

Indexed keywords

EID: 84890256389     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00222     Document Type: Review

References (177)

1. Abdelmoity, A. T., Hall, J. J., Bittel, D. C., and Yu, S. (2011). 1.39 Mb inherited interstitial deletion in 12p13.33 associated with developmental delay. Eur. J. Med. Genet. 54, 198-203. doi: 10.1016/j.ejmg.2010.11.010.
2. Adams, C. E., Yonchek, J. C., Schulz, K. M., Graw, S. L., Stitzel, J., Teschke, P. U., et al. (2012). Reduced Chrna7 expression in mice is associated with decreases in hippocampal markers of inhibitory function: implications for neuropsychiatric diseases. Neuroscience 207, 274-282. doi: 10.1016/j.neuroscience.2012.01.033.
3. Antzelevitch, C., Pollevick, G. D., Cordeiro, J. M., Casis, O., Sanguinetti, M. C., Aizawa, Y., et al. (2007). Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115, 442-449. doi: 10.1161/CIRCULATIONAHA.106.668392.
4. Ashley, C. T., Wilkinson, K. D., Reines, D., and Warren, S. T. (1993). FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262, 563-566. doi: 10.1126/science.7692601.
5. Audo, I., Kohl, S., Leroy, B. P., Munier, F. L., Guillonneau, X., Mohand-Saïd, S., et al. (2009). TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness. Am. J. Hum. Genet. 85, 720-729. doi: 10.1016/j.ajhg.2009.10.013.
6. Bader, P. L., Faizi, M., Kim, L. H., Owen, S. F., Tadross, M. R., Alfa, R. W., et al. (2011). Mouse model of Timothy syndrome recapitulates triad of autistic traits. Proc. Natl. Acad. Sci. U.S.A. 108, 15432-15437. doi: 10.1073/pnas.1112667108.
7. Barbon, A., and Barlati, S. (2011). Glutamate receptor RNA editing in health and disease. Biochemistry (Mosc.) 76, 882-889. doi: 10.1134/S0006297911080037.
8. Barrett, C. F., and Tsien, R. W. (2008). The Timothy syndrome mutation differentially affects voltage-and calcium-dependent inactivation of CaV1.2 L-type calcium channels. Proc. Natl. Acad. Sci. U.S.A. 105, 2157-2162. doi: 10.1073/pnas.0710501105.
9. Bartlett, T. E., Bannister, N. J., Collett, V. J., Dargan, S. L., Massey, P. V., Bortolotto, Z. A., et al. (2007). Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus. Neuropharmacology 52, 60-70. doi: 10.1016/j.neuropharm.2006.07.013.
10. Bateup, H. S., Johnson, C. A., Denefrio, C. L., Saulnier, J. L., Kornacker, K., and Sabatini, B. L. (2013). Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders. Neuron 78, 510-522. doi: 10.1016/j.neuron.2013.03.017.
11. Bateup, H. S., Takasaki, K. T., Saulnier, J. L., Denefrio, C. L., and Sabatini, B. L. (2011). Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function. J. Neurosci. 31, 8862-8869. doi: 10.1523/JNEUROSCI.1617-11.2011.
12. Ben-Ari, Y., Khalilov, I., Kahle, K. T., and Cherubini, E. (2012). The GABA excitatory/inhibitory shift in brain maturation and neurological disorders. Neuroscientist 18, 467-486. doi: 10.1177/1073858412438697.
13. Bender, A. C., Natola, H., Ndong, C., Holmes, G. L., Scott, R. C., and Lenck-Santini, P.-P. (2013). Focal Scn1a knockdown induces cognitive impairment without seizures. Neurobiol. Dis. 54, 297-307. doi: 10.1016/j.nbd.2012.12.021.
14. Berglund, J., Pollard, K. S., and Webster, M. T. (2009). Hotspots of biased nucleotide substitutions in human genes. PLoS Biol. 7:e26. doi: 10.1371/journal.pbio.1000026.
15. Berridge, M. J., Lipp, P., and Bootman, M. D. (2000). The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 11-21. doi: 10.1038/35036035.
16. Betzenhauser, M. J., and Marks, A. R. (2010). Ryanodine receptor channelopathies. Pflugers Arch. 460, 467-480. doi: 10.1007/s00424-010-0794-4.
17. Bezprozvanny, I., and Gargus, J. J. (2008). Calcium signaling disease. J. Gen. Physiol. 132, 1a-32a. doi: 10.1042/BST20110766.
18. Blumberg, S. J., Bramlett, M. D., Kogan, M. D., Schieve, L. A., Jones, J. R., and Lu, M. C. (2013). Changes in prevalence of parent-reported autism spectrum disorder in school-aged U. S. Children: 2007 to 2011-2012. National Health Statistics Reports no. 65. Hyattsville, MD: National Center for Health Statistics.
19. Bockenhauer, D., Feather, S., Stanescu, H. C., Bandulik, S., Zdebik, A. A., Reichold, M., et al. (2009). Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N. Engl. J. Med. 360, 1960-1970. doi: 10.1056/NEJMoa0810276.
20. Bokil, N. J., Baisden, J. M., Radford, D. J., and Summers, K. M. (2010). Molecular genetics of long QT syndrome. Mol. Genet. Metab. 101, 1-8. doi: 10.1016/j.ymgme.2010.05.011.
21. 2 responses in astrocytes. Br. J. Pharmacol. 164, 755-771. doi: 10.1111/j.1476-5381.2011.01421.x.
22. Brini, M., and Carafoli, E. (2011). Calcium signaling and disease: preface. Biofactors 37, 131. doi: 10.1002/biof.163.
23. TM (Internet), eds R. A. Pagon, T. D. Bird, C. R. Dolan, and K. Stephens (Seattle, WA: University of Washington).
24. Cain, S. M., and Snutch, T. P. (2011). Voltage-gated calcium channels and disease. Biofactors 37, 197-205. doi: 10.1002/biof.158.
25. Cao, Z., Hulsizer, S., Cui, Y., Pretto, D. L., Kim, K. H., Hagerman, P. J., et al. (2013). Enhanced asynchronous Ca2+ oscillations associated with impaired glutamate transport in cortical astrocytes expressing FMR1 gene premutation expansion. J. Biol. Chem. 288, 13831-13841. doi: 10.1074/jbc.M112.441055.
26. Carayol, J., Sacco, R., Tores, F., Rousseau, F., Lewin, P., Hager, J., et al. (2011). Converging evidence for an association of ATP2B2 allelic variants with autism in male subjects. Biol. Psychiatry 70, 880-887. doi: 10.1016/j.biopsych.2011.05.020.
27. Cassidy, S. B., Schwartz, S., Miller, J. L., and Driscoll, D. J. (2012). Prader-Willi syndrome. Genet. Med. 14, 10-26. doi: 10.1038/gim.0b013e31822bead0.
28. Catarino, C. B., Liu, J. Y. W., Liagkouras, I., Gibbons, V. S., Labrum, R. W., Ellis, R., et al. (2011). Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology. Brain 134(Pt 10), 2982-3010. doi: 10.1093/brain/awr129.
29. Chamberlain, S. J., and Lalande, M. (2010). Neurodevelopmental disorders involving genomic imprinting at human chromosome 15q11-q13. Neurobiol. Dis. 39, 13-20. doi: 10.1016/j.nbd.2010.03.011.
30. Chandy, K. G., Fantino, E., Wittekindt, O., Kalman, K., Tong, L. L., Ho, T. H., et al. (1998). Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: a candidate for schizophrenia and bipolar disorder? Mol. Psychiatry 3, 32-37. doi: 10.1038/sj.mp.4000353.
31. Chao, H.-T., Chen, H., Samaco, R. C., Xue, M., Chahrour, M., Yoo, J., et al. (2010). Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468, 263-269. doi: 10.1038/nature09582.
32. Chao, H.-T., Zoghbi, H. Y., and Rosenmund, C. (2007). MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56, 58-65. doi: 10.1016/j.neuron.2007.08.018.
33. Chen, C. P., Lin, S. P., Chern, S. R., Chen, Y. J., Tsai, F. J., Wu, P. C., et al. (2010). Array-CGH detection of a de novo 2.8 Mb deletion in 2q24.2→q24.3 in a girl with autistic features and developmental delay. Eur. J. Med. Genet. 53, 217-220. doi: 10.1016/j.ejmg.2010.03.006.
34. Cheng, E. P., Yuan, C., Navedo, M. F., Dixon, R. E., Nieves-Cintrón, M., Scott, J. D., et al. (2011). Restoration of normal L-type Ca2+ channel function during Timothy syndrome by ablation of an anchoring protein. Circ. Res. 109, 255-261. doi: 10.1161/CIRCRESAHA.111.248252.
35. Cohen, S., Gabel, H. W., Hemberg, M., Hutchinson, A. N., Sadacca, L. A., Ebert, D. H., et al. (2011). Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72, 72-85. doi: 10.1016/j.neuron.2011.08.022.
36. Collins, S. C., Bray, S. M., Suhl, J. A., Cutler, D. J., Coffee, B., Zwick, M. E., et al. (2010). Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males. Am. J. Med. Genet. A 152A, 2512-2520. doi: 10.1002/ajmg.a.33626.
37. Craig, A. K., de Menezes, M. S., and Saneto, R. P. (2012). Dravet syndrome: patients with co-morbid SCN1A gene mutations and mitochondrial electron transport chain defects. Seizure 21, 17-20. doi: 10.1016/j.seizure.2011.08.010.
38. Danial, N. N., Gramm, C. F., Scorrano, L., Zhang, C.-Y., Krauss, S., Ranger, A. M., et al. (2003). BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424, 952-956. doi: 10.1038/nature01825.
39. Deng, P.-Y., Rotman, Z., Blundon, J. A., Cho, Y., Cui, J., Cavalli, V., et al. (2013). FMRP regulates neurotransmitter release and synaptic information transmission by modulating action potential duration via BK channels. Neuron 77, 696-711. doi: 10.1016/j.neuron.2012.12.018.
40. Deng, P. Y., Sojka, D., and Klyachko, V. A. (2011). Abnormal presynaptic short-term plasticity and information processing in a mouse model of fragile X syndrome. J. Neurosci. 31, 10971-10982. doi: 10.1523/JNEUROSCI.2021-11.2011.
41. Depienne, C., Moreno-De-Luca, D., Heron, D., Bouteiller, D., Gennetier, A., Delorme, R., et al. (2009). Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disorders. Biol. Psychiatry 66, 349-359. doi: 10.1016/j.biopsych.2009.01.025.
42. Depil, K., Beyl, S., Stary-Weinzinger, A., Hohaus, A., Timin, E., Hering, S., et al. (2011). Timothy mutation disrupts the link between activation and inactivation in Ca(V)1.2 protein. J. Biol. Chem. 286, 31557-31564. doi: 10.1074/jbc.M111.255273.
43. De Rubeis, S., Fernández, E., Buzzi, A., Di Marino, D., and Bagni, C. (2012). Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis. Adv. Exp. Med. Biol. 970, 517-551. doi: 10.1007/978-3-7091-0932-8_23.
44. Devi, S., Markandeya, Y., Maddodi, N., Dhingra, A., Vardi, N., Balijepalli, R. C., et al. (2013). Metabotropic glutamate receptor 6 signaling enhances TRPM1 calcium channel function and increases melanin content in human melanocytes. Pigment Cell Melanoma Res. doi: 10.1111/pcmr.12083.
45. Devlin, B., and Scherer, S. W. (2012). Genetic architecture in autism spectrum disorder. Curr. Opin. Genet. Dev. 22, 229-237 doi: 10.1016/j.gde.2012.03.002.
46. Dichgans, M., Freilinger, T., Eckstein, G., Babini, E., Lorenz-Depiereux, B., Biskup, S., et al. (2005). Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366, 371-377. doi: 10.1016/S0140-6736(05)66786-4.
47. Dixon, R. E., Yuan, C., Cheng, E. P., Navedo, M. F., and Santana, L. F. (2012). Ca2+ signaling amplification by oligomerization of L-type Cav1.2 channels. Proc. Natl. Acad. Sci. U.S.A. 109, 1749-1754. doi: 10.1073/pnas.1116731109.
48. Dixon-Salazar, T. J., Keeler, L. C., Trauner, D. A., and Gleeson, J. G. (2004). Autism in several members of a family with generalized epilepsy with febrile seizures plus. J. Child Neurol. 19, 597-603. doi: 10.1177/088307380401900806.
49. Dodick, D. W., and Gargus, J. J. (2008). Why migraines strike. Sci. Am. 299, 56-63. doi: 10.1038/scientificamerican0808-56.
50. Du, W., Bautista, J. F., Yang, H., Diez-Sampedro, A., You, S. A., Wang, L., et al. (2005). Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nat. Genet. 37, 733-738. doi: 10.1038/ng1585.
51. Dykens, E. M., Lee, E., and Roof, E. (2011). Prader-Willi syndrome and autism spectrum disorders: an evolving story. J. Neurodev. Disord. 3, 225-237. doi: 10.1007/s11689-011-9092-5.
52. Ehninger, D., and Silva, A. J. (2011). Rapamycin for treating tuberous sclerosis and autism spectrum disorders. Trends Mol. Med. 17, 78-87. doi: 10.1016/j.molmed.2010.10.002.
53. Eichler, S. A., and Meier, J. C. (2008). E-I balance and human diseases-from molecules to networking. Front. Mol. Neurosci. 1:2. doi: 10.3389/neuro.02.002.2008.
54. Etheridge, S. P., Bowles, N. E., Arrington, C. B., Pilcher, T., Rope, A., Wilde, A. A. M., et al. (2011). Somatic mosaicism contributes to phenotypic variation in Timothy syndrome. Am. J. Med. Genet. A 155A, 2578-2583. doi: 10.1002/ajmg.a.34223.
55. Farra, N., Zhang, W.-B., Pasceri, P., Eubanks, J. H., Salter, M. W., and Ellis, J. (2012). Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations. Mol. Psychiatry 17, 1261-1271. doi: 10.1038/mp.2011.180.
56. Feng, Y., Zhang, F., Lokey, L. K., Chastain, J. L., Lakkis, L., Eberhart, D., et al. (1995). Translational suppression by trinucleotide repeat expansion at FMR1. Science 268, 731-734. doi: 10.1126/science.7732383.
57. Feske, S. (2010). CRAC channelopathies. Pflugers Arch. 460, 417-435. doi: 10.1007/s00424-009-0777-5.
58. Filipek, P. A. (2005). "Medical aspects of autism", in Handbook of Autism and Pervasive Developmental Disorders, eds F. R. Volkmar, A. Klin, R. Paul, and D. J. Cohen (New York: John Wiley and Sons), 534-578.
59. Fioravante, D., and Regehr, W. G. (2011). Short-term forms of presynaptic plasticity. Curr. Opin. Neurobiol. 21, 269-274. doi: 10.1016/j.conb.2011.02.003.
60. 2+-dysregulation aging phenotype in hippocampal neurons. J. Neurosci. 31, 1693-1703. doi: 10.1523/JNEUROSCI.4805-10.2011.
61. Gargus, J. J. (2003). Unraveling monogenic channelopathies and their implications for complex polygenic disease. Am. J. Hum. Genet. 72, 785-803. doi: 10.1086/374317.
62. Gargus, J. J. (2006). Ion channel functional candidate genes in multigenic neuropsychiatric disease. Biol. Psychiatry 60, 177-185. doi: 10.1016/j.biopsych.2005.12.008.
63. Gargus, J. J. (2008). "Receptor, transporter and ion channel diseases," in Neurobiology, Vol. 2, ed. R. A. Meyers (Weinheim: Wiley-VCH Verlag GmbH), 669-742.
64. Gargus, J. J. (2009). Genetic calcium signaling abnormalities in the central nervous system: seizures, migraine, and autism. Ann. N. Y. Acad. Sci. 1151, 133-56. doi: 10.1111/j.1749-6632.2008.03572.x.
65. Gargus, J. J. (2010). "Mitochondrial component of calcium signaling abnormality in autism," in Autism: Oxidative Stress, Inflammation and Immune Abnormalities, ed. A. Chauhan (Boca Rator: Taylor & Francis), 207-224.
66. Gargus, J. J., and Imtiaz, F. (2008). Mitochondrial energy-deficient endophenotype in autism. Am. J. Biochem. Biotechnol. 4, 198-207. doi: 10.3844/ajbbsp.2008.198.207.
67. Gargus, J. J., and Tournay, A. (2007). Novel mutation confirms seizure locus SCN1A is also FHM3 migraine locus. Pediatr. Neurol. 37, 407-410. doi: 10.1016/j.pediatrneurol.2007.06.016.
68. Gibson, J. R., Huber, K. M., and Südhof, T. C. (2009). Neuroligin-2 deletion selectively decreases inhibitory synaptic transmission originating from fast-spiking but not from somatostatin-positive interneurons. J. Neurosci. 29, 13883-13897. doi: 10.1523/JNEUROSCI.2457-09.2009.
69. Gilling, M., Rasmussen, H. B., Calloe, K., Sequeira, A. F., Baretto, M., Oliveira, G., et al. (2013). Dysfunction of the heteromeric KV7.3/KV7.5 potassium channel is associated with autism spectrum disorders. Front. Genet. 4:54. doi:10.3389/fgene.2013.00054.
70. Gillis, J., Burashnikov, E., Antzelevitch, C., Blaser, S., Gross, G., Turner, L., et al. (2012). Long QT, syndactyly, joint contractures, stroke and novel CACNA1C mutation: expanding the spectrum of Timothy syndrome. Am. J. Med. Genet. A 158A, 182-187. doi: 10.1002/ajmg.a.34355.
71. Girirajan, S., Dennis, M. Y., Baker, C., Malig, M., Coe, B. P., Campbell, C. D., et al. (2013). Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder. Am. J. Hum. Genet. 92, 221-237. doi: 10.1016/j.ajhg.2012.12.016.
72. Glaaser, I. W., Bankston, J. R., Liu, H., Tateyama, M., and Kass, R. S. (2006). A carboxyl-terminal hydrophobic interface is critical to sodium channel function. Relevance to inherited disorders. J. Biol. Chem. 281, 24015-24023. doi: 10.1074/jbc.M605473200.
73. Goetz, T., Arslan, A., Wisden, W., and Wulff, P. (2007). GABA(A) receptors: structure and function in the basal ganglia. Prog. Brain Res. 160, 21-41. doi: 10.1016/S0079-6123(06)60003-4.
74. Gogolla, N., Leblanc, J. J., Quast, K. B., Südhof, T. C., Fagiolini, M., Hensch, T. K., et al. (2009). Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J. Neurodev. Disord. 1, 172-181. doi: 10.1007/s11689-009-9023-x.
75. Green, E. K., Grozeva, D., Jones, I., Jones, L., Kirov, G., Caesar, S., et al. (2010). The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol. Psychiatry 15, 1016-1022. doi: 10.1038/mp.2009.49.
76. Gross, C., Yao, X., Pong, D. L., Jeromin, A., and Bassell, G. J. (2011). Fragile X mental retardation protein regulates protein expression and mRNA translation of the potassium channel Kv4.2. J. Neurosci. 31, 5693-5698. doi: 10.1523/JNEUROSCI.6661-10.2011.
77. Grube, S., Gerchen, M. F., Adamcio, B., Pardo, L. A., Martin, S., Malzahn, D., et al. (2011). A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia. EMBO Mol. Med. 3, 309-319. doi: 10.1002/emmm.201100135.
78. Hallmayer, J., Cleveland, S., Torres, A., Phillips, J., Cohen, B., Torigoe, T., et al. (2011). Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry 68, 1095-1102. doi: 10.1001/archgenpsychiatry.2011.76.
79. Han, S., Tai, C., Westenbroek, R. E., Yu, F. H., Cheah, C. S., Potter, G. B., et al. (2012). Autistic-like behaviour in Scn1a+/-mice and rescue by enhanced GABA-mediated neurotransmission. Nature 489, 385-390. doi: 10.1038/nature11356.
80. Hayashi, T., and Su, T. P. (2007). Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 131, 596-610. doi: 10.1016/j.cell.2007.08.036.
81. Hille, B. (2001). Ion Channels of Excitable Membranes, 3rd Edn. Sunderland, MA: Sinauer Associates).
82. Hoeffer, C. A., and Klann, E. (2010). mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 67-75. doi: 10.1016/j.tins.2009.11.003.
83. Hoeffer, C. A., Tang, W., Wong, H., Santillan, A., Patterson, R. J., Martinez, L. A., et al. (2008). Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior. Neuron 60, 832-845. doi: 10.1016/j.neuron.2008.09.037.
84. Hoppman-Chaney, N., Wain, K., Seger, P. R., Superneau, D. W., and Hodge, J. C. (2013). Identification of single gene deletions at 15q13.3: further evidence that CHRNA7 causes the 15q13.3 microdeletion syndrome phenotype. Clin. Genet. 83, 345-351. doi: 10.1111/j.1399-0004.2012.01925.x.
85. Huang, C. H., and Santangelo, S. L. (2008). Autism and serotonin transporter gene polymorphisms: a systematic review and meta-analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B, 903-913. doi: 10.1002/ajmg.b.30720.
86. Hübner, C. A., Stein, V., Hermans-Borgmeyer, I., Meyer, T., Ballanyi, K., and Jentsch, T. J. (2001). Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition. Neuron 30, 515-524. doi: 10.1016/S0896-6273(01)00297-5.
87. Ingason, A., Kirov, G., Giegling, I., Hansen, T., Isles, A. R., Jakobsen, K. D., et al. (2011). Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness. Am. J. Psychiatry 168, 408-417. doi: 10.1176/appi.ajp.2010.09111660.
88. Iossifov, I., Ronemus, M., Levy, D., Wang, Z., Hakker, I., Rosenbaum, J., et al. (2012). De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285-299. doi: 10.1016/j.neuron.2012.04.009.
89. Jacobs, A., Knight, B. P., McDonald, K. T., and Burke, M. C. (2006). Verapamil decreases ventricular tachyarrhythmias in a patient with Timothy syndrome (LQT8). Heart Rhythm 3, 967-970. doi: 10.1016/j.hrthm.2006.04.024.
90. Jacquemont, S., Hagerman, R. J., Leehey, M., Grigsby, J., Zhang, L., Brunberg, J. A., et al. (2003). Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am. J. Hum. Genet. 72, 869-878. doi: 10.1086/374321.
91. Johnstone, T. B., Gu, Z., Yoshimura, R. F., Villegier, A. S., Hogenkamp, D. J., Whittemore, E. R., et al. (2011). Allosteric modulation of related ligand-gated ion channels synergistically induces long-term potentiation in the hippocampus and enhances cognition. J. Pharmacol. Exp. Ther. 336:908-915 doi: 10.1124/jpet.110.176255.
92. Kang, J.-Q., and Barnes, G. (2013). A common susceptibility factor of both autism and epilepsy: functional deficiency of GABA A receptors. J. Autism Dev. Disord. 43, 68-79. doi: 10.1007/s10803-012-1543-7.
93. Kato, H. K., Kassai, H., Watabe, A. M., Aiba, A., and Manabe, T. (2012). Functional coupling of the metabotropic glutamate receptor, InsP3 receptor and L-type Ca2+ channel in mouse CA1 pyramidal cells. J. Physiol. 590(Pt 13), 3019-3034. doi: 10.1113/jphysiol.2012.232942.
94. Kim, J., Ghosh, S., Liu, H., Tateyama, M., Kass, R. S., Pitt, G. S., et al. (2004). Calmodulin mediates Ca2+ sensitivity of sodium channels. J. Biol. Chem. 279, 45004-45012. doi: 10.1074/jbc.M407286200.
95. Kim, S.-J., Silva, R. M., Flores, C. G., Jacob, S., Guter, S., Valcante, G., et al. (2011). A quantitative association study of SLC25A12 and restricted repetitive behavior traits in autism spectrum disorders. Mol. Autism 2, 8. doi: 10.1186/2040-2392-2-8.
96. Krey, J. F., Paşca, S. P., Shcheglovitov, A., Yazawa, M., Schwemberger, R., Rasmusson, R., et al. (2013). Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons. Nat. Neurosci. 16, 201-209. doi: 10.1038/nn.3307.
97. Kuriyama, K., Hirouchi, M., and Kimura, H. (2000). Neurochemical and molecular pharmacological aspects of the GABA(B) receptor. Neurochem. Res. 25, 1233-1239. doi: 10.1023/A:1007640027977.
98. Laumonnier, F., Roger, S., Guérin, P., Molinari, F., M'rad, R., Cahard, D., et al. (2006). Association of a functional deficit of the BKCa channel, a synaptic regulator of neuronal excitability, with autism and mental retardation. Am. J. Psychiatry 163, 1622-1629. doi: 10.1176/appi.ajp.163.9.1622.
99. Lee, H. Y., and Jan, L. Y. (2012). Fragile X syndrome: mechanistic insights and therapeutic avenues regarding the role of potassium channels. Curr. Opin. Neurobiol. 22, 887-894. doi: 10.1016/j.conb.2012.03.010.
100. Lemonnier, E., Degrez, C., Phelep, M., Tyzio, R., Josse, F., Grandgeorge, M., et al. (2012). A randomised controlled trial of bumetanide in the treatment of autism in children. Transl. Psychiatry 2, e202. doi: 10.1038/tp.2012.124.
101. Lepagnol-Bestel, A.-M., Maussion, G., Boda, B., Cardona, A., Iwayama, Y., Delezoide, A.-L., et al. (2008). SLC25A12 expression is associated with neurite outgrowth and is upregulated in the prefrontal cortex of autistic subjects. Mol. Psychiatry 13, 385-397. doi: 10.1038/sj.mp.4002120.
102. Li, H., Zhong, X., Chau, K. F., Williams, E. C., and Chang, Q. (2011). Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory. Nat. Neurosci. 14, 1001-1008. doi: 10.1038/nn.2866.
103. Li, X., Zou, H., and Brown, W. T. (2012). Genes associated with autism spectrum disorder. Brain Res. Bull. 88, 543-552. doi: 10.1016/j.brainresbull.2012.05.017.
104. Lin, H. C., Gean, P. W., Wang, C. C., Chan, Y. H., and Chen, P. S. (2013). The amygdala excitatory/inhibitory balance in a valproate-induced rat autism model. PLoS ONE 8:e55248. doi: 10.1371/journal.pone.0055248.
105. Liu, J., Koscielska, K. A., Cao, Z., Hulsizer, S., Grace, N., Mitchell, G., et al. (2012). Signaling defects in iPSC-derived fragile X premutation neurons. Hum. Mol. Genet. 21, 3795-3805. doi: 10.1093/hmg/dds207.
106. Liu, L., Wong, T. P., Pozza, M. F., Lingenhoehl, K., Wang, Y., Sheng, M., et al. (2004). Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 304, 1021-1024. doi: 10.1126/science.1096615.
107. Lu, A. T., Dai, X., Martinez-Agosto, J. A., and Cantor, R. M. (2012). Support for calcium channel gene defects in autism spectrum disorders. Mol. Autism 3, 18. doi: 10.1186/2040-2392-3-1.
108. Lynch, G., Larson, J., Kelso, S., Barrionuevo, G., and Schottler, F. (1983). Intracellular injections of EGTA block induction of hippocampal long-term potentiation. Nature 305, 719-721. doi: 10.1038/305719a0.
109. Ma, S., and Gargus, J. J. (2007). "The genetics of neuronal channelopathies," in Encyclopedia of Life Sciences (Chichester: John Wiley & Sons, Ltd). doi: 10.1002/9780470015902.a0020225.
110. Maclennan, D. H., and Zvaritch, E. (2011). Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum. Biochim. Biophys. Acta 1813, 948-964. doi: 10.1016/j.bbamcr.2010.11.009.
111. Mandell, D., and Knapp, M. (2012). Investing in our Future: The Economic Costs of Autism. Autism Speaks Available at: http://www.autismspeaks.org/science/science-news/autism%E2%80%99s-costs-nation-reach-137-billion-year.
112. Marchetto, M. C., Carromeu, C., Acab, A., Yu, D., Yeo, G. W., Mu, Y., et al. (2010). A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143, 527-539. doi: 10.1016/j.cell.2010.10.016.
113. Matta, J. A., Ashby, M. C., Sanz-Clemente, A., Roche, K. W., and Isaac, J. T. R. (2011). mGluR5 and NMDA receptors drive the experience-and activity-dependent NMDA receptor NR2B to NR2A subunit switch. Neuron 70, 339-351. doi: 10.1016/j.neuron.2011.02.045.
114. Mendez, M. A., Horder, J., Myers, J., Coghlan, S., Stokes, P., Erritzoe, D., et al. (2013). The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot ((11)C)Ro15-4513 positron emission tomography study. Neuropharmacology 68, 195-201. doi: 10.1016/j.neuropharm.2012.04.008.
115. Menold, M. M., Shao, Y., Wolpert, C. M., Donnelly, S. L., Raiford, K. L., Martin, E. R., et al. (2001). Association analysis of chromosome 15 gabaa receptor subunit genes in autistic disorder. J. Neurogenet. 15, 245-259. doi: 10.3109/01677060109167380.
116. Michalon, A., Sidorov, M., Ballard, T. M., Ozmen, L., Spooren, W., Wettstein, J. G., et al. (2012). Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron 74, 49-56. doi: 10.1016/j.neuron.2012.03.009.
117. Mironov, S. L., Skorova, E., Hartelt, N., Mironova, L. A., Hasan, M. T., Kügler, S., et al. (2009). Remodelling of the respiratory network in a mouse model of Rett syndrome depends on brain-derived neurotrophic factor regulated slow calcium buffering. J. Physiol. 587(Pt 11), 2473-2485. doi: 10.1113/jphysiol.2009.169805.
118. Morrow, E. M., Yoo, S. Y., Flavell, S. W., Kim, T. K., Lin, Y., Hill, R. S., et al. (2008). Identifying autism loci and genes by tracing recent shared ancestry. Science 321, 218-223. doi: 10.1126/science.1157657.
119. Muller, D., Joly, M., and Lynch, G. (1988). Contributions of quisqualate and NMDA receptors to the induction and expression of LTP. Science 242, 1694-1697. doi: 10.1126/science.2904701.
120. Myers, R. A., Casals, F., Gauthier, J., Hamdan, F. F., Keebler, J., Boyko, A. R., et al. (2011). A population genetic approach to mapping neurological disorder genes using deep resequencing. PLoS Genet. 7:e1001318. doi: 10.1371/journal.pgen.1001318.
121. Napolioni, V., Persico, A. M., Porcelli, V., and Palmieri, L. (2011). The mitochondrial aspartate/glutamate carrier AGC1 and calcium homeostasis: physiological links and abnormalities in autism. Mol. Neurobiol. 44, 83-92. doi: 10.1007/s12035-011-8192-2.
122. Neher, E., and Sakaba, T. (2008). Multiple roles of calcium ions in the regulation of neurotransmitter release. Neuron 59, 861-872. doi: 10.1016/j.neuron.2008.08.019.
123. Nelson, E. D., Kavalali, E. T., and Monteggia, L. M. (2006). MeCP2-dependent transcriptional repression regulates excitatory neurotransmission. Curr. Biol. 16, 710-716. doi: 10.1016/j.cub.2006.02.062.
124. O'Roak, B. J., Vives, L., Fu, W., Egertson, J. D., Stanaway, I. B., Phelps, I. G., et al. (2012a). Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338, 1619-22. doi: 10.1126/science.1227764.
125. O'Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., et al. (2012b). Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485, 246-250. doi: 10.1038/nature10989.
126. Ogden, K. K., and Traynelis, S. F. (2011). New advances in NMDA receptor pharmacology. Trends Pharmacol. Sci. 32, 726-733. doi: 10.1016/j.tips.2011.08.003.
127. Palmieri, L., Papaleo, V., Porcelli, V., Scarcia, P., Gaita, L., Sacco, R., et al. (2010). Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Mol. Psychiatry 15, 38-52. doi: 10.1038/mp.2008.63.
128. Paşca, S. P., Portmann, T., Voineagu, I., Yazawa, M., Shcheglovitov, A., Paşca, A. M., et al. (2011). Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat. Med. 17, 1657-1662. doi: 10.1038/nm.2576.
129. Patterson, R. L., Boehning, D., and Snyder, S. H. (2004). Inositol 1,4,5-trisphosphate receptors as signal integrators. Annu. Rev. Biochem. 73, 437-465. doi: 10.1146/annurev.biochem.73.071403.161303.
130. Persico, A. M., and Napolioni, V. (2013). Autism genetics. Behav. Brain Res. 251, 95-112. doi: 10.1016/j.bbr.2013.06.012.
131. Pietrobon, D. (2010). CaV2.1 channelopathies. Pflugers Arch. 460, 375-393. doi: 10.1007/s00424-010-0802-8.
132. Pizzarelli, R., and Cherubini, E. (2011). Alterations of GABAergic signaling in autism spectrum disorders. Neural Plast. 2011, 297153. doi: 10.1155/2011/297153.
133. Pizzarelli, R., and Cherubini, E. (2013). Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis. Front. Cell Neurosci. 7:85. doi: 10.3389/fncel.2013.00085.
134. Plummer, N. W., and Meisler, M. H. (1999). Evolution and diversity of mammalian sodium channel genes. Genomics 57, 323-331. doi: 10.1006/geno.1998.5735.
135. Prandini, P., Pasquali, A., Malerba, G., Marostica, A., Zusi, C., Xumerle, L., et al. (2012). The association of rs4307059 and rs35678 markers with autism spectrum disorders is replicated in Italian families. Psychiatric Genet. 22, 177-181. doi: 10.1097/YPG.0b013e32835185c9.
136. Psychiatric Genomics Consortium, Smoller, J. W., Craddock, N., Kendler, K., Lee, P. H., Neale, B. M., et al. (2013). Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371-1379. doi: 10.1016/S0140-6736(12)62129-1.
137. Qiu, Z., and Cheng, J. (2010). The role of calcium-dependent gene expression in autism spectrum disorders: lessons from MeCP2, Ube3a and beyond. Neurosignals 18, 72-81. doi: 10.1159/000320970.
138. Ramanathan, A., and Schreiber, S. L. (2009). Direct control of mitochondrial function by mTOR. Proc. Natl. Acad. Sci. U.S.A. 106, 22229-22232. doi: 10.1073/pnas.0912074106.
139. Ramoz, N., Reichert, J. G., Smith, C. J., Silverman, J. M., Bespalova, I. N., Davis, K. L., et al. (2004). Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Am. J. Psychiatry 161, 662-669. doi: 10.1176/appi.ajp.161.4.662.
140. Relkovic, D., Doe, C. M., Humby, T., Johnstone, K. A., Resnick, J. L., Holland, A. J., et al. (2010). Behavioural and cognitive abnormalities in an imprinting centre deletion mouse model for Prader-Willi syndrome. Eur. J. Neurosci. 31, 156-164. doi: 10.1111/j.1460-9568.2009.07048.x.
141. Ronald, A., and Hoekstra, R. A. (2011). Autism spectrum disorders and autistic traits: a decade of new twin studies. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156B, 255-274. doi: 10.1002/ajmg.b.31159.
142. Ronesi, J. A., Collins, K. A., Hays, S. A., Tsai, N.-P., Guo, W., Birnbaum, S. G., et al. (2012). Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome. Nat. Neurosci. 15, 431-440, S1. doi: 10.1038/nn.3033.
143. Sadakata, T., Shinoda, Y., Oka, M., Sekine, Y., Sato, Y., Saruta, C., et al. (2012). Reduced axonal localization of a Caps2 splice variant impairs axonal release of BDNF and causes autistic-like behavior in mice. Proc. Natl. Acad. Sci. U.S.A. 109, 21104-21109. doi: 10.1073/pnas.1210055109.
144. Sadakata, T., Washida, M., Iwayama, Y., Shoji, S., Sato, Y., Ohkura, T., et al. (2007). Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients. J. Clin. Invest. 117, 931-943. doi: 10.1172/JCI29031.
145. Saleh, S., Yeung, S. Y., Prestwich, S., Pucovsky, V., and Greenwood, I. (2005). Electrophysiological and molecular identification of voltage-gated sodium channels in murine vascular myocytes. J. Physiol. 568(Pt 1), 155-169. doi: 10.1113/jphysiol.2005.090951.
146. Samaco, R. C., Hogart, A., and LaSalle, J. M. (2005). Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum. Mol. Genet. 14, 483-492. doi: 10.1093/hmg/ddi045.
147. Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., et al. (2012). De novo mutations revealed by whole-exome sequencing ares trongly associated with autism. Nature 485, 237-241. doi: 10.1038/nature10945.
148. Segurado, R., Conroy, J., Meally, E., Fitzgerald, M., Gill, M., and Gallagher, L. (2005). Confirmation of association between autism and the mitochondrial aspartate/glutamate carrier SLC25A12 gene on chromosome 2q13. Am. J. Psychiatry 162, 2182-2184. doi: 10.1176/appi.ajp.162.11.2182.
149. Sharma, A., Hoeffer, C. A., Takayasu, Y., Miyawaki, T., McBride, S. M., Klann, E., et al. (2010). Dysregulation of mTOR signaling in fragile X syndrome. J. Neurosci. 30, 694-702. doi: 10.1523/JNEUROSCI.3696-09.2010.
150. Sheridan, S. D., Theriault, K. M., Reis, S. A., Zhou, F., Madison, J. M., Daheron, L., et al. (2011). Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS ONE 6:e26203. doi: 10.1371/journal.pone.0026203.
151. Sicca, F., Imbrici, P., D'Adamo, M. C., Moro, F., Bonatti, F., Brovedani, P., et al. (2011). Autism with seizures and intellectual disability: possible causative role of gain-of-function of the inwardly-rectifying K+ channel Kir4.1. Neurobiol. Dis. 43, 239-247. doi: 10.1016/j.nbd.2011.03.016.
152. Sicouri, S., Timothy, K. W., Zygmunt, A. C., Glass, A., Goodrow, R. J., Belardinelli, L., et al. (2007). Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine. Heart Rhythm 4, 638-647. doi: 10.1016/j.hrthm.2006.12.046.
153. Skafidas, E., Testa, R., Zantomio, D., Chana, G., Everall, I. P., and Pantelis, C. (2012). Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Mol. Psychiatry doi: 10.1038/mp.2012.126 [Epub ahead of print].
154. Sklar, P., Smoller, J. W., Fan, J., Ferreira, M. A. R., Perlis, R. H., Chambert, K., et al. (2008). Whole-genome association study of bipolar disorder. Mol. Psychiatry 13, 558-569. doi: 10.1038/sj.mp.4002151.
155. Smith, M., Flodman, P. L., Gargus, J. J., Simon, M. T., Verrell, K., Haas, R., et al. (2012). Mitochondrial and ion channel gene alterations in autism. Biochim. Biophys. Acta 1817, 1796-1802. doi: 10.1016/j.bbabio.2012.04.004.
156. Spät, A., Szanda, G., Csordás, G., and Hajnóczky, G. (2008). High-and low-calcium-dependent mechanisms of mitochondrial calcium signalling. Cell Calcium 44, 51-63. doi: 10.1016/j.ceca.2007.11.015.
157. Splawski, I., Timothy, K. W., Decher, N., Kumar, P., Sachse, F. B., Beggs, A. H., et al. (2005). Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc. Natl. Acad. Sci. U.S.A. 102, 8089-8096. doi: 10.1073/pnas.0502506102.
158. TM (Internet), eds R. A. Pagon, T. D. Bird, C. R. Dolan, and K. Stephens (Seatlle: GeneReviews, University of Washington), 1993-2013.
159. Splawski, I., Timothy, K. W., Sharpe, L. M., Decher, N., Kumar, P., Bloise, R., et al. (2004). Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19-31. doi: 10.1016/j.cell.2004.09.011.
160. Splawski, I., Yoo, D. S., Stotz, S. C., Cherry, A., Clapham, D. E., Keating, M. T., et al. (2006). CACNA1H mutations in autism spectrum disorders. J. Biol. Chem. 281, 22085-22091. doi: 10.1074/jbc.M603316200.
161. Strom, S. P., Stone, J. L., Ten Bosch, J. R., Merriman, B., Cantor, R. M., Geschwind, D. H., et al. (2010). High-density SNP association study of the 17q21 chromosomal region linked to autism identifies CACNA1G as a novel candidate gene. Mol. Psychiatry 15, 996-1005. doi: 10.1038/mp.2009.41.
162. Strom, T. M., Nyakatura, G., Apfelstedt-Sylla, E., Hellebrand, H., Lorenz, B., Weber, B. H., et al. (1998). An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat. Genet. 19, 260-263. doi: 10.1038/940.
163. Stutzmann, G. E., Smith, I., Caccamo, A., Oddo, S., Laferla, F. M., Parker, I., et al. (2006). Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice. J. Neurosci. 26, 5180-5189. doi: 10.1523/JNEUROSCI.0739-06.2006.
164. Szabadkai, G., and Duchen, M. R. (2008). Mitochondria: the hub of cellular Ca2+ signaling. Physiology (Bethesda) 23, 84-94. doi: 10.1152/physiol.00046.2007.
165. Tang, Z. Z., Sharma, S., Zheng, S., Chawla, G., Nikolic, J., Black, D. L., et al. (2011). Regulation of the mutually exclusive exons 8a and 8 in the CaV1.2 calcium channel transcript by polypyrimidine tract-binding protein. J. Biol. Chem. 286, 10007-10016. doi: 10.1074/jbc.M110.208116.
166. Thimm, M., Kircher, T., Kellermann, T., Markov, V., Krach, S., Jansen, A., et al. (2011). Effects of a CACNA1C genotype on attention networks in healthy individuals. Psychol. Med. 41, 1551-1561. doi: 10.1017/S0033291710002217.
167. Tsai, P. T., Hull, C., Chu, Y., Greene-Colozzi, E., Sadowski, A. R., Leech, J. M., et al. (2012). Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 488, 647-651. doi: 10.1038/nature11310.
168. Turunen, J. A., Rehnström, K., Kilpinen, H., Kuokkanen, M., Kempas, E., and Ylisaukko-Oja, T. (2008). Mitochondrial aspartate/glutamate carrier SLC25A12 gene is associated with autism. Autism Res. 1, 189-192. doi: 10.1002/aur.25.
169. Veeramah, K. R., O'Brien, J. E., Meisler, M. H., Cheng, X., Dib-Hajj, S. D., Waxman, S. G., et al. (2012). De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am. J. Hum. Genet. 90, 502-510. doi: 10.1016/j.ajhg.2012.01.006.
170. Vorstman, J. A. S., Staal, W. G., Van Daalen, E., Van Engeland, H., Hochstenbach, P. F. R., and Franke, L. (2006). Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol. Psychiatry 11, 1, 18-28. doi: 10.1038/sj.mp.4001757.
171. Wafford, K. A. (2005). GABAA receptor subtypes: any clues to the mechanism of benzodiazepine dependence? Curr. Opin. Pharmacol. 5, 47-52. doi: 10.1016/j.coph.2004.08.006.
172. Wallace, R. H., Wang, D. W., Singh, R., Scheffer, I. E., George, A. L. Jr., Phillips, H. A., et al. (1998). Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat. Genet. 19, 366-370. doi: 10.1038/448.
173. Wang, H.-S, Pan, Z., Shi, W., Brown, B. S., Wymore, R. S., Cohen, I. S., et al. (1998). KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 282, 1890-1893. doi: 10.1126/science.282.5395.1890.
174. Weiss, L. A., Escayg, A., Kearney, J. A., Trudeau, M., MacDonald, B. T., Mori, M., et al. (2003). Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Mol. Psychiatry 8, 186-194. doi: 10.1038/sj.mp.4001241.
175. Yang, W., Liu, J., Zheng, F., Jia, M., Zhao, L., Lu, T., et al. (2013). The evidence for association of ATP2B2 polymorphisms with autism in Chinese Han population. PLoS ONE 8:e61021. doi: 10.1371/journal.pone.0061021. 1.
176. Yasui, D. H., Scoles, H. A., Horike, S.-I., Meguro-Horike, M., Dunaway, K. W., Schroeder, D. I., et al. (2011). 15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain. Hum. Mol. Genet. 20, 4311-4323. doi: 10.1093/hmg/ddr357.
177. Yazawa, M., Hsueh, B., Jia, X., Paşca, A. M., Bernstein, J. A., Hallmayer, J., et al. (2011). Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 471, 230-234. doi: 10.1038/nature09855.